Key Highlights

  • A strong fiscal first quarter and an upgrade to Overweight sent Mercury Systems (NASDAQ:MRCY) up 5.7% on November 11, 2026 by one closing measure, while other market summaries put the advance at nearly 13%.
  • Adjusted Earnings came in at USD 0.52 per share, twice the USD 0.26 consensus, and Revenue grew 12.4% to USD 253.2 million, ahead of the USD 244.8 million expected.
  • A record USD 370 million of bookings, up 48%, produced a book-to-bill ratio of 1.46 and pushed Backlog up roughly 45% to close to USD 2.1 billion.
  • For fiscal 2027, management lifted its adjusted EBITDA outlook to about USD 210 million and now sees revenue nearing USD 1.1 billion, with double-digit growth.

The Quarter That Settled the Profitability Debate

Processing, radio frequency and secure computing subsystems for missiles, radars, aircraft and space platforms are the core of what Mercury Systems (NASDAQ:MRCY) sells. For years, the question hanging over the stock was whether a big defence backlog could be turned into profitable growth, given earlier programme charges and execution missteps. The fiscal first quarter, released on the evening of November 10, 2026, went a long way toward answering it. Revenue rose 12.4% to USD 253.2 million, ahead of forecasts, and adjusted EBITDA surged 58.6% to USD 56 million, a 22.3% margin. On a GAAP basis, the company earned USD 0.21 per share, against a loss of USD 0.21 a year before. Free Cash Flow was negative USD 24 million, yet management attributed this to inventory bought on purpose to support expected growth, not to operating trouble. The difference is meaningful: a company stocking up against firm orders is in a far better spot than one absorbing cost overruns. Growth, Margin and order intake all improved together, something that had not happened in several reporting periods.

Orders, Backlog and the Rating Change

Order intake was the highlight. Bookings climbed 48% to a record USD 370 million, for a book-to-bill ratio of 1.46, and backlog rose 44.7% to nearly USD 2.1 billion. That pipeline underpins the higher guidance. Fiscal 2027 revenue is now expected to approach USD 1.1 billion, with double-digit growth, and adjusted EBITDA of about USD 210 million replaces an earlier view approaching USD 200 million. Revenue in the second quarter is projected to grow about 10%. The next day, a large US research firm moved the shares to Overweight, calling the results a proof point on the adjusted EBITDA margin target and saying robust bookings give clear sight of double-digit sales growth. Sources disagree on the exact move, with one summary showing 5.68% and another nearly 13%, but each shows a sharp gain. Canadian investors can reach the stock through a US-listed line at their Canadian brokerage.

Execution Risks and Items to Monitor

The backdrop for defence budgets is supportive, as the present geopolitical climate keeps Demand for munitions, air defence and secure processing high. Still, Mercury (NASDAQ:MRCY) carries execution risk. The company has been hurt by fixed-price development contracts in the past, and a fresh cost overrun could quickly erase margin gains. Free cash flow has to turn positive as inventory converts into deliveries, and higher interest rates make it costlier to fund working capital. Watchers will focus on three items through the second half of the fiscal year: bookings staying above revenue, margins holding above 20% and cash generation getting better.

Where Things Stand

Mercury Systems (NASDAQ:MRCY) advanced on November 11, 2026 following a fiscal first quarter that featured adjusted earnings of USD 0.52 per share, record bookings of USD 370 million and backlog near USD 2.1 billion. The company lifted its fiscal 2027 adjusted EBITDA view to about USD 210 million and earned an Overweight upgrade. Cash flow and contract execution are the next hurdles for a Business now priced on growth rather than recovery. That change in story matters for valuation, since defence electronics suppliers with steady growth tend to earn higher multiples than turnaround situations.